About this Journal Submit a Manuscript Table of Contents
Journal of Skin Cancer
Volume 2013 (2013), Article ID 327150, 9 pages
http://dx.doi.org/10.1155/2013/327150
Review Article

Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic Options

Universitätsklinik für Dermatologie, AKH, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090 Wien, Austria

Received 25 July 2012; Accepted 10 December 2012

Academic Editor: Boban M. Erovic

Copyright © 2013 Laura Desch and Rainer Kunstfeld. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [18 citations]

The following is the list of published articles that have cited the current article.

  • Ahmed Abu-Zaid, Ayman Azzam, Ahmed Al-Wusaibie, Maraei Bin Makhashen, Abdulaziz Jarman, and Tarek Amin, “Merkel Cell Carcinoma of Left Groin: A Case Report and Literature Review,” Case Reports in Oncological Medicine, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • F. Kleffner, J. Schürholz, S. Burckhardt, C. Mauch, and M. Schlaak, “Merkel-Zell-Karzinom,” Der Hautarzt, vol. 65, no. 9, pp. 823–832, 2014. View at Publisher · View at Google Scholar
  • Jennifer Tseng, Birat Dhungel, Jane K. Mills, Brian S. Diggs, Roshanthi Weerasinghe, Jeanine Fortino, and John T. Vetto, “Merkel Cell Carcinoma: What Makes a Difference?,” The American Journal of Surgery, 2014. View at Publisher · View at Google Scholar
  • Monique E Verhaegen, Doris Mangelberger, Jack W Weick, Tracy D Vozheiko, Paul W Harms, Kevin T Nash, Elsa Quintana, Paul Baciu, Timothy M Johnson, Christopher K Bichakjian, and Andrzej A Dlugosz, “Merkel Cell Carcinoma Dependence on Bcl-2 Family Members for Survival,” Journal of Investigative Dermatology, 2014. View at Publisher · View at Google Scholar
  • Uwe Wollina, “Update of cetuximab for non-melanoma skin cancer,” Expert Opinion on Biological Therapy, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Anshul Saxena, Muni Rubens, Venkataraghavan Ramamoorthy, and Hafiz Khan, “Risk of Second Cancers in Merkel Cell Carcinoma: A Meta-Analysis of Population Based Cohort Studies,” Journal of Skin Cancer, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Loren Masterson, Bryan J. Thibodeau, Laura E. Fortier, Timothy J. Geddes, Barbara L. Pruetz, Rajwant Malhotra, Richard Keidan, and George D. Wilson, “Gene Expression Differences Predict Treatment Outcome of Merkel Cell Carcinoma Patients,” Journal of Skin Cancer, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Lorena Barboza-Guadagnini, María José Fuente-González, and Carlos Ferrandiz-Foraster, “Estrategia diagnóstica y terapéutica en el carcinoma de Merkel,” Piel, 2015. View at Publisher · View at Google Scholar
  • Celeste Lebbe, Jürgen C. Becker, Jean-Jacques Grob, Josep Malvehy, Veronique del Marmol, Hubert Pehamberger, Ketty Peris, Philippe Saiag, Mark R. Middleton, Lars Bastholt, Alessandro Testori, Alexander Stratigos, and Claus Garbe, “Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline,” European Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Andrew J. Bishop, Adam S. Garden, G. Brandon Gunn, David I. Rosenthal, Beth M. Beadle, Clifton D. Fuller, Lawrence B. Levy, Ann M. Gillenwater, Merrill S. Kies, Bita Esmaeli, Steven J. Frank, Jack Phan, and William H. Morrison, “Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy,” Head & Neck, 2015. View at Publisher · View at Google Scholar
  • Brett A. Miles, and David Goldenberg, “Merkel cell carcinoma: Do you know your guidelines?,” Head & Neck, 2015. View at Publisher · View at Google Scholar
  • Yezaz A. Ghouri, Somashekar G. Krishna, Uma R. Kundu, Manoop S. Butani, Jeffrey H. Lee, and William A. Ross, “A Case Series and Literature Review of Merkel Cell Carcinoma Metastasizing to Pancreas,” Digestive Diseases and Sciences, vol. 60, no. 6, pp. 1805–1812, 2015. View at Publisher · View at Google Scholar
  • Christian A. Grayes, Ashley Jones, Justin Reynolds, Jeremy Stuart, Lucia Pirisi, Peter Botrous, and James Wells, “Neuroendocrine Merkel Cell Carcinoma Is Associated with Mutations in Key DNA Repair, Epigenetic and Apoptosis Pathways: A Case-Based Study Using Targe,” Neuroendocrinology, vol. 101, no. 2, pp. 112–119, 2015. View at Publisher · View at Google Scholar
  • Alok T. Saini, and Brett A. Miles, “Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options,” Oncotargets And Therapy, vol. 8, 2015. View at Publisher · View at Google Scholar
  • Eligijus Poškus, Gediminas Platkevičius, Vilma Simanskaitė, Ernesta Rimkevičiūtė, Marius Petrulionis, and Kestutis Strupas, “Multiple gastrointestinal metastases of Merkel cell carcinoma,” Medicina, 2016. View at Publisher · View at Google Scholar
  • Howard L Kaufman, Jeffery Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Sandra P D'Angelo, Kent C Shih, Céleste Lebbé, Gerald P Linette, Michele Milella, Isaac Brownell, Karl D Lewis, Jochen H Lorch, Kevin Chin, Lisa Mahnke, Anja von Heydebreck, Jean-Marie Cuillerot, and Paul Nghiem, “Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial,” The Lancet Oncology, 2016. View at Publisher · View at Google Scholar
  • Nicole M. Cassler, Dean Merrill, Christopher K. Bichakjian, and Isaac Brownell, “Merkel Cell Carcinoma Therapeutic Update,” Current Treatment Options in Oncology, vol. 17, no. 7, 2016. View at Publisher · View at Google Scholar
  • R. U. Wahl, T. Braunschweig, A. Ghassemi, and A. Ruebben, “Immunotherapy with imiquimod and interferon alfa for metastasized Merkel cell carcinoma,” Current Oncology, vol. 23, no. 2, pp. E150–E153, 2016. View at Publisher · View at Google Scholar